Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical · Travel Services

Booking Holdings logoBooking Holdings

BKNG · a US exchange · USD · Market cap $118.4B · 24,900 employees

Booking Holdings Inc., together with its subsidiaries, provides online and traditional travel and restaurant reservations and related services in the United States, the Netherlands, the United Kingdom, and internationally.

FAIL · Does not pass the screen
147.32 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price147.32 USD at the 19 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 19 Nov 2026
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans slightly to calls (put/call 0.79)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $202.24 to $306.56, base estimate $242.33 (screen dated 2026-11-19).

Current read
Distribution ?
Undervalued · screened 2026-11-19
  • Trend Distribution
  • Insiders insiders sold, $244,590, latest filing 2026-10-15
  • Positioning political selling, disclosed 2026-10-13
  • Options put/call open interest 0.79, read 2026-11-18
  • Ethical does not pass the values gate
Price147.32 USD
Fair value242.33
Ethical score10.0/100
Value readUndervaluedas of 19 Nov 2026
Our investment reviews on this name
2026-11-17Read Distribution159.58-7.7% to today ✓Markup gives way to Distribution
2026-11-10Read Markup163.49-9.9% to today Distribution gives way to Markup after an 11% rise in 12 days
2026-10-29Read Distribution147.94-0.4% to today ✓Markup gives way to Distribution after an 11% slide in 2 days
2026-10-27Read Markup165.80-11.1% to today Distribution gives way to Markup first Markup read since August

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Booking Holdings holds its Distribution at $147.32. Consolidating, no directional conviction, held for 9 days.

As held on the ledger · 2026-11-19
PhaseDistribution · caution
Quantitative stateConsolidating, no directional conviction, held for 9 days
Price at the screen$147.32
Valuation17.27 trailing · 12.99 forward price to earnings
Values screenFAIL · score 10.0
Beta1.15
The Workings

Five Screens: BKNG's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 65.93% Below 33% Fail
Interest-bearing cash 1.99% Below 33% Pass
Receivables 71.84% Below 49% Fail
Revenue purity 3.42% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Booking's business is in a permissible area, but its interest-bearing debt is about 66% of the company, well over the ~33% line, so it does not pass on the financial screens. Its receivables are also high.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when BKNG's ethical verdict changes

Today BKNG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 39% discount to our $242.33 fair value.

Model construction and limits: fair-value methodology.

202.24Conservative242.33Base case306.56Growth case 147.32Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 39.2% discount to the base estimate.

The Street's Range
150.00Street low 215.00Street average 267.00Street high 147.32Price

Third-party analyst targets: 35 covering, consensus Buy. The average target sits +46% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $242.33, with a range of $202.24 to $306.56, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E13.0xreasonably valued
Trailing P/E17.3xreasonably valued
EPS, trailing9.22
EPS, forward12.26
Revenue growth-1.3%revenue is shrinking
Profit margin25.5%healthy profit margins
FCF yield6.42%
Dividend yield1.09%
Current ratio1.12adequate liquidity, worth monitoring
Beta1.15moves a little more than the market
Short interest, float0.03%
52-week range146.28 - 220.81
Market cap$118.4B
Employees24,900

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-17 Distribution · changed $159.58 -2.4% Entry 24

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter.

2026-11-10 Markup · changed $163.49 +10.4% Entry 23

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter.

2026-11-03 Distribution $148.13 +0.0% Entry 22

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-02 Distribution $148.13 +0.0% Entry 21

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-01 Distribution $148.13 -1.5% Entry 20

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-31 Distribution $150.43 +0.0% Entry 19

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-30 Distribution $150.43 +1.7% Entry 18

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-29 Distribution · changed $147.94 -10.8% Entry 17

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Markup $165.80 +0.0% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Markup · changed $165.80 +0.0% Entry 15

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (35 analysts) rates it buy, with a mean price target of $224. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on BKNG

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in BKNG's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · BKNG
DateInsiderTitleTypeSharesValue
2026-10-15 Pisano Paulo CHRO S - Sale 1,500 $244,590
2026-05-26 Millones Peter J EVP, GC Sale 62,500 $10,229,456
2026-04-17 Wittman Vanessa Ames Dir Sale 1,125 $216,000
2026-04-15 Fogel Glenn D CEO, Pres Sale 16,726 $3,100,294
2026-03-13 Fogel Glenn D CEO, Pres Sale 669 $2,871,413
2026-02-17 Fogel Glenn D CEO, Pres Sale 452 $1,875,688
2026-02-17 Fogel Glenn D CEO, Pres Sale 560 $2,291,979
2026-02-02 Mylod Robert J Jr Dir Sale 40 $204,214
2026-01-15 Fogel Glenn D CEO, Pres Sale 60 $312,486
2026-01-15 Fogel Glenn D CEO, Pres Sale 953 $4,937,816

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming BKNG
DatePoliticianPartyTypeAmount
2026-10-13 Ro Khanna Democrat sell 1K–15K
2026-10-07 Ro Khanna Democrat sell 15K–50K
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $162.60 -5.7% · $943 -5.7%
2 months $167.90 -8.7% · $913 -8.7%
3 months $209.36 -26.8% $0.42 $734 -26.6%
6 months $160.27 -4.4% $0.84 $962 -3.8%
1 year $189.58 -19.2% $1.64 $817 -18.3%
2 years $197.47 -22.4% $3.15 $792 -20.8%
3 years $122.51 +25.1% $4.20 $1,285 +28.5%
5 years $91.43 +67.6% $4.20 $1,722 +72.2%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever BKNG does next, these words stay.

Booking Holdings · BKNG · Distribution · $147.32
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.